Spear Bio, Inc.

About Spear Bio, Inc.

Spear Bio, Inc. is a biotechnology company focused on developing next-generation protein therapeutics using its proprietary computational platform to design and optimize biologics with enhanced stability, efficacy, and manufacturability. The company leverages machine learning and structural biology to target challenging disease areas, including oncology and immunology, with a pipeline of engineered antibodies and protein-based drugs. Spear Bio aims to overcome limitations of traditional biologics by creating molecules that resist degradation and maintain function in harsh physiological conditions. The company collaborates with pharmaceutical partners and has received funding from venture capital firms specializing in life sciences innovation. Its work sits at the intersection of AI-driven drug discovery and protein engineering, positioning it as a leader in the emerging field of computational biologics design.